| Product Code: ETC11478021 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cancer Immunotherapies Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cancer Immunotherapies Market Revenues & Volume, 2021 & 2031F |
3.3 China Cancer Immunotherapies Market - Industry Life Cycle |
3.4 China Cancer Immunotherapies Market - Porter's Five Forces |
3.5 China Cancer Immunotherapies Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 China Cancer Immunotherapies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Cancer Immunotherapies Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Cancer Immunotherapies Market Revenues & Volume Share, By Mechanism, 2021 & 2031F |
4 China Cancer Immunotherapies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of cancer in China |
4.2.2 Growing awareness and adoption of immunotherapy treatments |
4.2.3 Supportive government initiatives and policies for cancer research and treatment |
4.3 Market Restraints |
4.3.1 High cost of immunotherapies |
4.3.2 Limited access to advanced immunotherapy treatments in rural areas of China |
5 China Cancer Immunotherapies Market Trends |
6 China Cancer Immunotherapies Market, By Types |
6.1 China Cancer Immunotherapies Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 China Cancer Immunotherapies Market Revenues & Volume, By Therapy Type, 2021 - 2031F |
6.1.3 China Cancer Immunotherapies Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F |
6.1.4 China Cancer Immunotherapies Market Revenues & Volume, By Immune Checkpoint Inhibitors, 2021 - 2031F |
6.2 China Cancer Immunotherapies Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Cancer Immunotherapies Market Revenues & Volume, By Hematological Cancers, 2021 - 2031F |
6.2.3 China Cancer Immunotherapies Market Revenues & Volume, By Solid Tumors, 2021 - 2031F |
6.3 China Cancer Immunotherapies Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Cancer Immunotherapies Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.3 China Cancer Immunotherapies Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4 China Cancer Immunotherapies Market, By Mechanism |
6.4.1 Overview and Analysis |
6.4.2 China Cancer Immunotherapies Market Revenues & Volume, By Immune System Modulation, 2021 - 2031F |
6.4.3 China Cancer Immunotherapies Market Revenues & Volume, By Tumor Suppression, 2021 - 2031F |
7 China Cancer Immunotherapies Market Import-Export Trade Statistics |
7.1 China Cancer Immunotherapies Market Export to Major Countries |
7.2 China Cancer Immunotherapies Market Imports from Major Countries |
8 China Cancer Immunotherapies Market Key Performance Indicators |
8.1 Patient survival rates post-immunotherapy treatment |
8.2 Number of clinical trials for cancer immunotherapies in China |
8.3 Level of investment in cancer immunotherapy research and development in China |
9 China Cancer Immunotherapies Market - Opportunity Assessment |
9.1 China Cancer Immunotherapies Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 China Cancer Immunotherapies Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Cancer Immunotherapies Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Cancer Immunotherapies Market Opportunity Assessment, By Mechanism, 2021 & 2031F |
10 China Cancer Immunotherapies Market - Competitive Landscape |
10.1 China Cancer Immunotherapies Market Revenue Share, By Companies, 2024 |
10.2 China Cancer Immunotherapies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here